Skip to main content
SpringerLink
Log in

Hämatologische Probleme

  • Chapter
Neugeborenen-intensivmedizin

  • 1428 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 29.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Aladangady N, McHugh S, Aitchison TC, Wardrop CA, Holland BM (2006) Infants’ blood volume in a controlled trial of placental transfusion at preterm delivery. Pediatrics 117:93–98

    PubMed  Google Scholar 

  2. American Academy of Pediatrics Committee on Fetus and Newborn (2003) Controversies concerning vitamin K and the newborn. Pediatrics 112:191–192

    Google Scholar 

  3. Amir J, Metzker A, Krikler R, Reisner SH (1986) Strawberry hemangioma in preterm infants. Pediatr Dermatol 3:331–332

    PubMed  CAS  Google Scholar 

  4. Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen DM, Castle V, Powers P (1988) Development of the human coagulation system in the healthy premature infant. Blood 72:1651–1657

    PubMed  CAS  Google Scholar 

  5. Awonusonu FO, Pauly TH, Hutchison AA (2002) Maternal smoking and partial exchange transfusion for neonatal polycythemia. Am J Perinatol 19:349–354

    PubMed  Google Scholar 

  6. Bader D, Kugelman A, Maor-Rogin N, Weinger-Abend M, Hershkowitz S, Tamir A, Lanir A, Attias D, Barak M (2001) The role of high-dose oral iron supplementation during erythropoietin therapy for anemia of prematurity. J Perinatol 21:215–220

    PubMed  CAS  Google Scholar 

  7. Balk R, Emerson T, Fourrier F, Kruse JA, Mammen EF, Schuster HP, Vinazzer H (1998) Therapeutic use of antithrombin concentrate in sepsis. Semin Thromb Hemost 24:183–194

    PubMed  CAS  Google Scholar 

  8. Bednarek FJ, Weisberger S, Richardson DK, Frantz ID 3rd, Shah B, Rubin LP (1998) Variations in blood transfusion among newborn intensive care units. J Pediatr 133:601–607

    PubMed  CAS  Google Scholar 

  9. Bell EF, Strauss RG, Widness JA, Mahoney LT, Mock DM, Seward VJ, Cress GA, Johnson KJ, Kromer IJ, Zimmerman MB (2005) Randomized trial of liberal versus restrictive guidelines for red blood cell transfusion in preterm infants. Pediatrics 115:1685–1691

    PubMed  Google Scholar 

  10. Blanchette VS, Johnson J, Rand M (2000) The management of alloimmune neonatal thrombocytopenia. Baillieres Best Pract Res Clin Haematol 13: 365–390

    PubMed  CAS  Google Scholar 

  11. Blanchette V, Kühne T, Hume H, Hellmann J (1995) Platelet transfusion therapy in newborn infants. Transfus Med Rev 9:215–230

    PubMed  CAS  Google Scholar 

  12. Blanchette V, Chen L, Salomon de Friedberg Z, Hogan VA, Trudel E, Decary F (1990) Alloimmunization to the PlA1 platelet antigen: results of a prospective study. Br J Haematol 74:209–215

    PubMed  CAS  Google Scholar 

  13. Blanchette V, Andrew M, Perlman M, Ling E, Ballin A (1989) Neonatal autoimmune thrombocytopenia: Role of high-dose intravenous immonuglobulin G therapy. Blut 59:139–144

    PubMed  CAS  Google Scholar 

  14. Boven K, Stryker S, Knight J, Thomas A, van Regenmortel M, Kemeny DM, Power D, Rossert J, Casadevall N (2005) The increased incidence of pure red cell aplasia with an Eprex formulation in uncoated rubber stopper syringes. Kidney Int 67:2346–2353

    PubMed  Google Scholar 

  15. Boven K, Knight J, Bader F, Rossert J, Eckardt KU, Casadevall N (2005) Epoetin-associated pure red cell aplasia in patients with chronic kidney disease: solving the mystery. Nephrol Dial Transplant 20Suppl 3:iii33–40

    PubMed  CAS  Google Scholar 

  16. Brown MS, Jones MA, Ohls RK, Christensen RD (1993) Single-dose pharmacokinetics of recombinant human erythropoietin in preterm infants after intravenous and subcutaneous administration. J Pediatr 122:655–657

    PubMed  CAS  Google Scholar 

  17. Bundesministerium der Justiz (2005) Bekannmachung der Richtlinien zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten (Hämotherapie) gemäß §§ 12 und 18 des Transfusionsgesetzes (TFG) (Novelle 2005). BAnz 209a

    Google Scholar 

  18. Bussel JB (2001) Alloimmune thrombocytopenia in the fetus and newborn. Semin Thromb Hemost 27: 245–252

    PubMed  CAS  Google Scholar 

  19. Cook RL, Miller RC, Katz VL, Cefalo RC (1991) Immune thrombocytopenic purpura in pregnancy: a reappraisal of management. Obstet Gynecol 78: 578–583

    PubMed  CAS  Google Scholar 

  20. Cornelissen M, von Kries R, Loughnan P, Schubiger G (1997) Prevention of vitamin K deficiency bleeding: efficacy of different multiple oral dose schedules of vitamin K. Eur J Pediatr 156:126–130

    PubMed  CAS  Google Scholar 

  21. Crowther CA, Henderson-Smart DJ (2000) Vitamin K prior to preterm birth for preventing neonatal periventricular haemorrhage. Cochrane Database Syst Rev: CD000229

    Google Scholar 

  22. Dani C, Reali MF, Bertini G, Martelli E, Pezzati M, Rubaltelli FF (2001) The role of blood transfusions and iron intake on retinopathy of prematurity. Early Hum Dev 62:57–63

    PubMed  CAS  Google Scholar 

  23. Davoren A, Curtis BR, Aster RH, McFarland JG (2004) Human platelet antigen-specific alloantibodies implicated in 1162 cases of neonatal alloimmune thrombocytopenia. Transfusion 44:1220–1225

    PubMed  CAS  Google Scholar 

  24. Dempsey EM, Barrington K (2005) Crystalloid or colloid for partial exchange transfusion in neonatal polycythemia: a systematic review and meta-analysis. Acta Paediatr 94:1650–1655

    PubMed  Google Scholar 

  25. deWaal KA, Baerts W, Offringa M (2006) Systematic review of the optimal fluid for dilutional exchange transfusion in neonatal polycythaemia. Arch Dis Child 91:F7–10

    CAS  Google Scholar 

  26. Dreyfus M, Kaplan C, Verdy E, Schlegel N, Durand-Zaleski I, Tchernia G and the Immune Throm-bocytopenia Working Group (1997) Frequency of immune thrombocytopenia in newborns: a prospective study. Blood 89:4402–4406

    PubMed  CAS  Google Scholar 

  27. Forestier F, Daffos F, Catherine N, Renard M, Andreux JP (1991) Developmental hematopoiesis in normal human fetal blood. Blood 77:2360–2363

    PubMed  CAS  Google Scholar 

  28. Franz AR, Pohlandt F (2001) Red blood cell transfusions in very and extremely low birthweight infants under restrictive transfusion guidelines: is exogenous erythropoietin necessary? Arch Dis Child 84:F96–F100

    CAS  Google Scholar 

  29. Franz AR, Mihatsch WA, Sander S, Kron M, Pohlandt F (2000) Prospective randomized trial of early versus late enteral iron supplementation in infants with a birth weight of less than 1301 grams. Pediatrics 106:700–706

    PubMed  CAS  Google Scholar 

  30. Garcia MG, Hutson AD, Christensen RD (2002) Effect of recombinant erythropoietin on »late« transfusions in the neonatal intensive care unit: a meta-analysis. J Perinatol 22:108–111

    PubMed  Google Scholar 

  31. Gill KK, Kelton JG (2000) Management of idiopathic thrombocytopenic purpura in pregnancy. Semin Hematol 37:275–289

    PubMed  CAS  Google Scholar 

  32. Goldman M, Filion M, Proulx C, Chartrand P, DŽcary F (1994) Neonatal alloimmune thrombocytopenia. Transfus Med Rev 8:123–131

    PubMed  CAS  Google Scholar 

  33. Groß SJ, Filston HC, Andersen JC (1982) Controlled study of treatment for disseminated intravascular coagulation in the neonate. J Pediatr 100:445–448

    PubMed  Google Scholar 

  34. Host H, Ulrich M (1982) Late prognosis in untreated neonatal polycythaemia with minor or no symptoms. Acta Paediatr Scand 71:629–633

    PubMed  CAS  Google Scholar 

  35. Hume H (1997) Red blood cell transfusions for preterm infants: the role of evidence-based medicine. Seminars in Perinatology 21:8–19

    PubMed  CAS  Google Scholar 

  36. Kaplan C (2002) Alloimmune thrombocytopenia of the fetus and the newborn. Blood Rev 16:69–72

    PubMed  CAS  Google Scholar 

  37. Kaplan C, Morel-Kopp MC, Clemenceau S, Daffos F, Forestier F, Tchernia G (1992) Fetal and neonatal alloimmune thrombocytopenia: current trends in diagnosis and therapy. Transfus Med 2: 265–271

    PubMed  CAS  Google Scholar 

  38. Keyes WG, Donohue PK, Spivak JL, Jones MD Jr, Oski FA (1989) Assessing the need for transfusion of premature infants and role of hematocrit, clinical signs and erythropoietin level. Pediatrics 84:412–417

    PubMed  CAS  Google Scholar 

  39. Kiefel V, Kroll H, Mueller-Eckhardt C (1994) Neonatale Alloimmunthrombozytopenie. Dtsch Med Wochenschr 119: 1512–1517

    PubMed  CAS  Google Scholar 

  40. Kleihauer E, Hildegard B, Betke K (1957) Demonstration von fetalem Hämoglobin in den Erythrozyten eines Blutausstrichs. Klin Wochenschr 35: 637–638

    PubMed  CAS  Google Scholar 

  41. Kotto-Kome AC, Garcia MG, Calhoun DA, Christensen RD (2004) Effect of beginning recombinant erythropoietin treatment within the first week of life, among very-low-birth-weight neonates, on »early« and »late« erythrocyte transfusions: a meta-analysis. J Perinatol 24:24–29

    PubMed  CAS  Google Scholar 

  42. Kreuz W, Veldmann A, Fischer D, Schlosser R, Volk WR, Ettingshausen CE (1999) Neonatal sepsis: a challenge in hemostaseology. Semin Thromb Hemost 25:531–535

    PubMed  CAS  Google Scholar 

  43. Kries R von, Hachmeister A, Gobel U (2003) Oral mixed micellar vitamin K for prevention of late vitamin K deficiency bleeding. Arch Dis Child 88:F109–F112

    Google Scholar 

  44. Kries R von, Hachmeister A, Gobel U (1999) Can 3 oral 2 mg doses of vitamin K effectively prevent late vitamin K deficiency bleeding? Eur J Pediatr 158Suppl 3: S183–186

    Google Scholar 

  45. Kries R von (1999) Oral versus intramuscular phytomenadione: safety and efficacy compared. Drug Saf 21:1–6

    Google Scholar 

  46. Kries R von, Göbel U (1994) Oral vitamin K prophylaxis and late haemorrhagic disease of the newborn. Lancet 343:352

    Google Scholar 

  47. Kroll H, Bein G (1999) Neonatale Autoimmunthrombozytopenie. Dtsch Med Wschr 124: 1435–1436

    PubMed  CAS  Google Scholar 

  48. Kroll H, Kiefel V, Santoso S (1998) Clinical aspects and typing of platelet alloantigens. Vox Sang 74(Suppl 2): 345–354

    PubMed  CAS  Google Scholar 

  49. Lane PA, Hathaway WE (1985) Vitamin K in infancy. J Pediatr 106:351–359

    PubMed  CAS  Google Scholar 

  50. Lee DA, Slagle TA, Jackson TM, Evans CS (1995) Reducing blood donor exposures in low birth weight infants by the use of older, unwashed packed red J Pediatr 126:280–286

    PubMed  CAS  Google Scholar 

  51. Letsky EA, Greaves M (1996) On behalf of the Maternal and Neonatal Haemostasis Working Party of the Haemostasis and Thrombosis Task Force of the British Society for Haematology. Guidelines on the investigation and management of thrombocytopenia in pregnancy and neonatal alloimmune thrombocytopenia. Br J Haematol 95: 21–26

    PubMed  CAS  Google Scholar 

  52. Leung SP (2000) Multiple strawberry haemangiomas-side effect of rhuEpo? Acta Paediatr 89:890

    PubMed  CAS  Google Scholar 

  53. Liu EA, Mannino FL, Lane TA (1994) Prospective, randomized trial of the safety and efficacy of a limited donor exposure transfusion program for premature neonates. J Pediatr 125:92–96

    PubMed  CAS  Google Scholar 

  54. Maier RF, Obladen M, Müller-Hansen I et al. (2002) Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. J Pediatr 141:8–15

    PubMed  CAS  Google Scholar 

  55. Maier R F, Sonntag J, Walka M M, Liu G, Metze B C, Obladen M (2000) Changing practices of red blood cell transfusions in infants with birth weights less than 1000 g. J Pediatr 136:220–224

    PubMed  CAS  Google Scholar 

  56. Maier R F, Metze B, Obladen M (1998) Low degree of regionalization and high transfusion rates in very low birthweight infants: A survey in Germany. J Perinat Med 26:43–48

    PubMed  CAS  Google Scholar 

  57. Maier RF, Obladen M, Kattner E et al. (1998) High-versus low-dose erythropoietin in extremely low birth weight infants. Pediatrics 132:866–870

    CAS  Google Scholar 

  58. Maier RF, Obladen M, Scigalla P et al. (1994) The effect of epoietin Beta (recombinant human erythropoietin) on the need for transfusion in very low birth weight infants. N Engl J Med 330:1173–1178

    PubMed  CAS  Google Scholar 

  59. Mehta P, Vasa R, Neumann L, Karpatkin M (1980) Thrombocytopenia in the highrisk infant. J Pediatr 97:791–794

    PubMed  CAS  Google Scholar 

  60. Meyer MP, Meyer JH, Commerford A, Hann FM, Sive AA, Moller G, Jacobs P, Malan AF (1994) Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study. Pediatrics 93:918–923

    PubMed  CAS  Google Scholar 

  61. Millard FE, McMillan R (1990) Chronic idiopathic thrombocytopenic purpura and pregnancy. In: Bern MM, Frigolette FD (eds) Hematologic disorders in maternal-fetal medicine. Wiley-Liss, New York, pp 361–389

    Google Scholar 

  62. Mouzinho A, Rosenfeld CD, Sanchesz PJ, Risser R (1994) Revised reference ranges for circulating neutrophils in very low birth weight neonates. Pediatrics 94:76–82

    PubMed  CAS  Google Scholar 

  63. Mueller-Eckhardt C (1990) Platelet allo-and autoantigens and their clinical implications. In: Nance SJ (ed) Transfusion medicine in the 1990’s. American Association of Blood Banks, Arlington, pp 63–93

    Google Scholar 

  64. Mueller-Eckhardt C, Kiefel V, Grubert A (1989) High-dose IgG treatment for neonatal alloimmune thrombocytopenia. Blut 59:145–146

    PubMed  CAS  Google Scholar 

  65. Murphy MF, Verjee S, Greaves M (1999) Inadequacies in the postnatal management of fetomaternal alloimmune thrombocytopenia (FMAIT). Br J Haematol 105: 123–126

    PubMed  CAS  Google Scholar 

  66. Nathan DG, Orkin SH, Look AT (2003) Nathan and Oski’s Hematology of infancy and childhood. 6th Ed. WB Saunders, Philadelphia

    Google Scholar 

  67. Norman M, Fagrell B, Herin P (1992) Effects of neonatal polycythemia and hemodilution on capillary perfusion. J Pediatr 121:103–108

    PubMed  CAS  Google Scholar 

  68. Nutrition Committee, Canadian Paediatric Society (1995) Nutrient needs and feeding of premature infants. Can Med Assoc J 152:1765–1785

    Google Scholar 

  69. Obladen M, Diepold K, Maier R F (2000) Venous and arterial hematologic profiles of very low birthweight infants. Pediatrics 106:707–711

    PubMed  CAS  Google Scholar 

  70. Obladen M, Maier RF, Bührer C (1999) Use of cytokines in the neonate. In: Ganser A, Hoelzer D (eds) Cytokines in the treatment of hematopoietic failure. Marcel Decker, New York: pp 249–281

    Google Scholar 

  71. Obladen M, Sachsenweger M, Stahnke M (1988) Blood sampling in very low birth weight infants on different intensive care levels. Eur J Pediatr 147:399–404

    PubMed  CAS  Google Scholar 

  72. Ohls RK, Ehrenkranz RA, Das A et al. (2004) Neurodevelopmental outcome and growth at 18 to 22 months’ corrected age in extremely low birth weight infants treated with early erythropoietin and iron. Pediatrics 114:1287–1291

    PubMed  Google Scholar 

  73. Ohls RK, Osborne KA, Christensen RD (1995) Efficacy and cost analysis of treating very low birth weight infants with erythropoietin during their first two weeks of life: a randomized, placebo-controlled trial. J Pediatr 126:421–426

    PubMed  CAS  Google Scholar 

  74. Paul DA, Leef KH, Locke RG, Stefano JL (2002) Transfusion volume in infants with very low birth weight: a randomized trial of 10 versus 20 ml/kg. J Pediatr Hematol Oncol 24:43–46

    PubMed  Google Scholar 

  75. Pearlman SA, Meek RS, Cowchock FS, Smith JB, McFarland J, Aster RH (1992) Neonatal alloimmune thrombocytopenia after maternal immunization with paternal mononuclear cells: successful treatment with intravenous gamma globulin. Am J Perinatol 9:448–451

    PubMed  CAS  Google Scholar 

  76. Pereira SP, Shearer MJ, Williams R, Mieli-Vergani G (2003) Intestinal absorption of mixed micellar phylloquinone (vitamin K1) is unreliable in infants with conjugated hyperbilirubinaemia: implications for oral prophylaxis of vitamin K deficiency bleeding. Arch Dis Child 88:F113–F118

    CAS  Google Scholar 

  77. Puckett RM, Offringa M (2000) Prophylactic vitamin K for vitamin K deficiency bleeding in neonates. Cochrane Database Syst Rev CD002776

    Google Scholar 

  78. Rabe H, Reynolds G, Diaz-Rossello J (2004) Early versus delayed umbilical cord clamping in preterm infants. Cochrane Database Syst Rev: CD003248

    Google Scholar 

  79. Ramamurthy RS, Bryan YW (1981) Neonatal polycythemia. I. Criteria for diagnosis and treatment. Pediatrics 68:168–174

    PubMed  CAS  Google Scholar 

  80. Ranasinghe E, Walton JD, Hurd CM, Saul L, Smith G, Campbell K, Ouwehand WH (2001) Provision of platelet support for fetuses and neonates affected by severe fetomaternal alloimmune thrombocytopenia. Br J Haematol 113: 40–42

    PubMed  CAS  Google Scholar 

  81. Rayment R, Brunskill SJ, Stanworth S, Soothill PW, Roberts DJ, Murphy MF (2005) Antenatal interventions for fetomaternal alloimmune thrombocytopenia. Cochrane Database Syst Rev:CD004226

    Google Scholar 

  82. Ringer SA, Richardson DK, Sacher RA, Keszler M, Churchill WH (1998) Variations in transfusion practice in neonatal intensive care. Pediatrics 101:194–200

    PubMed  CAS  Google Scholar 

  83. Roithmaier A, Arlettaz R, Bauer K, Bucher HU, Krieger M, Duc G, Versmold HAT (1995) Randomized controlled trial of Ringer solution versus serum for partial exchange transfusion in neonatal polycythaemia. Eur J Pediatr 154:53–56

    PubMed  CAS  Google Scholar 

  84. Romagnoli C, Zecca E, Gallini F, Girlando P, Zuppa AA (2000) Do recombinant human erythropoietin and iron supplementation increase the risk of retinopathy of prematurity? Eur J Pediatr 159:627–628

    PubMed  CAS  Google Scholar 

  85. Roseff SD, Luban NLC, Manno CS (2002) Guidelines for assessing appropriateness of pediatric transfusion. Transfusion 42: 1398–1413

    PubMed  Google Scholar 

  86. Rosenkrantz TS (2003) Polycythemia and hyperviscosity in the newborn. Semin Thromb Hemost 29:515–527

    PubMed  Google Scholar 

  87. Rosenkranz TS, Ob W (1982) Cerebral blood flow velocity in infants with polycythemia and hyperviscosity: Effects of partial exchange transfusion with plasmanate. J Pediatr 10l:94–98

    Google Scholar 

  88. Ross MP, Christensen RD, Rothstein G, Koenig JM, Simmons MA, Noble NA, Kimura RE (1989) A randomized trial to develop criteria for administering erythrocyte transfusions to anemic preterm infants 1 to 3 months of age. J Perinatol 9:246–253

    PubMed  CAS  Google Scholar 

  89. Sainio S, Jarvenpaa AL, Renlund M, Riikonen S, Teramo K, Kekomaki R (2000) Thrombocytopenia in term infants: a population-based study. Obstet Gynecol 95:441–446

    PubMed  CAS  Google Scholar 

  90. Scarcella A, Gambardella P (1986) Partial exchange transfusion using peripheral vessels in polycythaemic newborn infants. Eur J Pediatr 145:545–546

    Google Scholar 

  91. Schelonka RL, Yoder BA, desJardins SE, Hall RB, Butler TJ (1994) Peripheral leukocyte count and leukocyte indexes in healthy newborn term infants. J Pediatr 125:603–606

    PubMed  CAS  Google Scholar 

  92. Schimmel MS, Bromiker R, Soll RF (2004) Neonatal polycythemia: is partial exchange transfusion justified? Clin Perinatol 31:545–553

    PubMed  Google Scholar 

  93. Schmidt BK, Muraji T, Zipursky A (1986) Low antithrombin III in neonatal shock: DIC or non-specific protein depletion? Eur J Pediatr 145:500–503

    PubMed  CAS  Google Scholar 

  94. Schubiger G, Berger TM, Weber R, Banziger O, Laubscher B; Swiss Paediatric Surveillance Unit. (2003) Prevention of vitamin K deficiency bleeding with oral mixed micellar phylloquinone: results of a 6-year surveillance in Switzerland. Eur J Pediatr 162:885–888

    PubMed  CAS  Google Scholar 

  95. Schuster HP (1998) Epilogue: disseminated intravascular coagulation and antithrombin III in intensive care medicine: pathophysiological insights and therapeutic hopes. Semin Thromb Hemost 24:81–83

    PubMed  CAS  Google Scholar 

  96. Shannon KM, Keith JF 3rd, Mentzer WC et al. (1995) Recombinant human Erythropoietin stimulates Erythropoiesis and reduces transfusions in preterm infants. Pediatrics 95:1–8

    PubMed  CAS  Google Scholar 

  97. Shapiro AD, Jacobson LI, Armon ME, Manco-Johnson MJ, Hulac P, Lane PA, Hathaway WE (1986) Vitamin K deficiency in the newborn infant: Prevalence and perinatal risk factors. J Pediatr 109:675–680

    PubMed  CAS  Google Scholar 

  98. Sharon R, Tatarsky I (1994) Low fetal morbidity in pregnancy associated with acute and chronic idiopathic thrombocytopenic purpura. Am J Hematol 46: 87–90

    PubMed  CAS  Google Scholar 

  99. Shirahata A, Shirakawa Y, Murakami C (1998) Diagnosis of DIC in very low birth weight infants. Semin Thromb Hemost 24:467–471

    PubMed  CAS  Google Scholar 

  100. Siimes MA, Jarvenpää AL (1982) Prevention of anemia and iron deficiency in very low birth weight infants. J Pediatr 101:277–280

    PubMed  CAS  Google Scholar 

  101. Sola MC, Del Vecchio A, Rimsza LM (2000) Evaluation and treatment of thrombocytopenia in the neonatal intensive care unit. Clin Perinatol 27:655–679

    PubMed  CAS  Google Scholar 

  102. Strauss RG, Burmeister LF, Johnson K, Cress G, Cordle D (2000) Feasibility and safety of AS-3 red blood cells for neonatal transfusions. J Pediatr 136:215–219

    PubMed  CAS  Google Scholar 

  103. Strauss RG, Burmeister LF, Johnson K, Cress G, Cordle DG (2000) Randomized trial assessing the feasibility and safety of biologic parents as RBC donors for their preterm infants. Transfusion 40:450–456

    PubMed  CAS  Google Scholar 

  104. Strauss RG, Burmeister LF, Johnson K, James T, Miller J, Cordle DG, Bell EF, Ludwig GA (1996) AS-1 red cells for neonatal transfusions: a randomized trial assessing donor exposure and safety. Transfusion 36:873–878

    PubMed  CAS  Google Scholar 

  105. Strauss RG (1991) Transfusion therapy in neonates. Am J Dis Child 145:904–911

    PubMed  CAS  Google Scholar 

  106. Strauss RG, Bell EF, Snyder EL, Elbert C et al. (1986) Effects of environmental warming on blood components dispensed in syringes for neonatal transfusions. J Pediatr 109:109–113

    PubMed  CAS  Google Scholar 

  107. Sutor AH, von Kries R, Cornelissen EA, McNinch AW, Andrew M (1999) Vitamin K deficiency bleeding (VKDB) in infancy. ISTH Pediatric/Perinatal Subcommittee. International Society on Thrombosis and Haemostasis. Thromb Haemost 81:456–461

    PubMed  CAS  Google Scholar 

  108. Suzuki S, Morishita S (1998) Hypercoagulability and DIC in high-risk infants. Semin Thromb Hemost 24:463–466

    PubMed  CAS  Google Scholar 

  109. Swetman SM, Yabek SM, Alverson DC (1987) Hemodynamic consequences of neonatal polycythemia. J Pediatr 110:443–447

    Google Scholar 

  110. Thomas L (1998) Labor und Diagnose. Indikation und Bewertung von Laborbefunden für die medizinische Diagnostik. 5. Aufl. TH-Books, Frankfurt, S. 282

    Google Scholar 

  111. Thurlbeck SM, McIntosh N (1987) Preterm blood counts vary with sampling site. Arch Dis Child 62:74–75

    PubMed  CAS  Google Scholar 

  112. Vamvakas EC, Strauss RG (2001) Meta-analysis of controlled clinical trials studying the efficacy of rHuEPO in reducing blood transfusions in the anemia of prematurity. Transfusion 41:406–415

    PubMed  CAS  Google Scholar 

  113. Walka MM, Sonntag J, Kage A, Dudenhausen JW, Obladen M (1998) Complete blood counts from umbilical cords of healthy term newborns by two automated cytometers. Acta Haematol 100:167–173

    PubMed  CAS  Google Scholar 

  114. Warwood TL, Ohls RK, Wiedmeier SE, Lambert DK, Jones C, Scoffield SH, Neeraj G, Veng-Pedersen P, Christensen RD (2005) Single-dose darbepoetin administration to anemic preterm neonates. J Perinatol 25:725–730

    PubMed  CAS  Google Scholar 

  115. Weiss M, Fischer J, Boeckmann M, Rohrer B, Baenziger O (2001) Evaluation of a simple method for minimizing iatrogenic blood loss from discard volumes in critically ill newborns and children. Intensive Care Med 27:1064–1072

    PubMed  CAS  Google Scholar 

  116. Widness JA, Madan A, Grindeanu LA, Zimmerman MB, Wong DK, Stevenson DK (2005) Reduction in red blood cell transfusions among preterm infants: results of a randomized trial with an in-line blood gas and chemistry monitor. Pediatrics 115:1299–1306

    PubMed  Google Scholar 

  117. Widness JA, Seward VJ, Kromer IJ, Burmeister LF, Bell EF, Strauss RG (1996) Changing patterns of red blood cell transfusion in very low birth weight infants. J Pediatr 125: 680–687

    Google Scholar 

  118. Williamson LM, Hackett G, Rennie J, Palmer CR, Maciver C, Hadfield R, Hughes D, Jobson S, Ouwehand WH (1998) The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening. Blood 92: 2280–2287

    PubMed  CAS  Google Scholar 

  119. Wiswell TE. Cornish ID, Northam RS (1986) Neonatal polycythemia: Frequency of clinical manifestations and other associated findings. Pediatrics 78:26–30

    PubMed  CAS  Google Scholar 

  120. Wong W, Fok TF, Lee CH, Ng PC, So KW, Ou Y, Cheung KL (1997) Randomised controlled trial: comparison of colloid or crystalloid for partial exchange transfusion for treatment of neonatal polycythaemia. Arch Dis Child 77:F115–F118

    CAS  Google Scholar 

  121. Wood A, Wilson N, Skacel P, Thomas R, Tidmarsh E, Yale C, de Silva M (1995) Reducing donor exposure in preterm infants requiring multiple blood transfusions. Arch Dis Child 72:F29–F33

    CAS  Google Scholar 

  122. Xanthou M, Bracci R, Prindull G (eds) (1993) Neonatal haematology and immunology II. Elsevier, Amsterdam

    Google Scholar 

  123. Zaffanello M, Franchini M, Rugolotto S (2003) Recombinant human erythropoietin might induce strawberry haemangiomas in very-low-birthweight preterm infants. Acta Paediatr 92:1353–1354

    PubMed  CAS  Google Scholar 

  124. Zaizov R, Matoth Y (1976) Red cell values on the first postnatal day during the last 16 weeks of gestation. Am J Hematol 1:275–278

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. R. F. Maier
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Charité Virchow-Klinikum, Augustenburger Platz 1, 13353, Berlin

    Michael Obladen (Direktor der Klinik für Neonatologie) (Direktor der Klinik für Neonatologie)

  2. Universitätsklinikum Gießen/Marburg GmbH, Standort Marburg, Baldinger Straße, 35043, Marburg

    Rolf F. Maier (Direktor des Zentrums für Kinder- und Jugendmedizin) (Direktor des Zentrums für Kinder- und Jugendmedizin)

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Maier, R.F. (2006). Hämatologische Probleme. In: Obladen, M., Maier, R.F. (eds) Neugeborenen-intensivmedizin. Springer, Berlin, Heidelberg . https://doi.org/10.1007/978-3-540-33738-6_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-33738-6_15

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-33737-9

  • Online ISBN: 978-3-540-33738-6

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation